{
     "PMID": "25142190",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160501",
     "LR": "20140821",
     "IS": "1601-5215 (Electronic) 0924-2708 (Linking)",
     "VI": "26",
     "IP": "3",
     "DP": "2014 Jun",
     "TI": "Effects of acute administration of mazindol on brain energy metabolism in adult mice.",
     "PG": "146-54",
     "LID": "10.1017/neu.2013.43 [doi]",
     "AB": "OBJECTIVES: Mazindol is a sympathomimetic amine, widely used as an anorectic agent in the treatment of obesity. This drug causes psychostimulant effects because of its pharmacological profile similar to amphetamine, acting like a monoamine reuptake inhibitor. However, the mechanisms underlying the action of mazindol are still not clearly understood. METHODS: Swiss mice received a single acute administration of mazindol (0.25, 1.25 and 2.5 mg/kg, ip) or saline. After 2 h, the animals were killed by decapitation; the brain was removed and used for the evaluation of activities of mitochondrial respiratory chain complexes, Krebs cycle enzymes and creatine kinase. RESULTS: Acute administration of mazindol decreased complex I activity only in the hippocampus. Complex IV activity was increased in the cerebellum (2.5 mg/kg) and cerebral cortex (0.25 mg/kg). Citrate synthase activity was increased in the cerebellum (1.25 mg/kg) and cerebral cortex (1.25 mg/kg), and creatine kinase activity was increased in the cerebellum (1.25 mg/kg). CONCLUSION: We suggest that the inhibition of complex I in the hippocampus only and activation of complex IV, citrate synthase and creatine kinase occurs because of a stimulus effect of mazindol in the central nervous system, which causes a direct impairment on energy metabolism.",
     "FAU": [
          "Goncalves, Cinara Ludvig",
          "Scaini, Giselli",
          "Rezin, Gislaine Tezza",
          "Jeremias, Isabela Casagrande",
          "Bez, Gisele Daiane",
          "Daufenbach, Juliana Felipe",
          "Gomes, Lara Mezari",
          "Ferreira, Gabriela Kozuchovski",
          "Zugno, Alexandra Ioppi",
          "Streck, Emilio Luiz"
     ],
     "AU": [
          "Goncalves CL",
          "Scaini G",
          "Rezin GT",
          "Jeremias IC",
          "Bez GD",
          "Daufenbach JF",
          "Gomes LM",
          "Ferreira GK",
          "Zugno AI",
          "Streck EL"
     ],
     "AD": "1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. 2 Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina, Porto Alegre, RS, Brazil. 1 Laboratorio de Bioenergetica, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Acta Neuropsychiatr",
     "JT": "Acta neuropsychiatrica",
     "JID": "9612501",
     "RN": [
          "0 (Central Nervous System Stimulants)",
          "C56709M5NH (Mazindol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/*drug effects/*metabolism",
          "Central Nervous System Stimulants/administration & dosage/*pharmacology/therapeutic use",
          "Energy Metabolism/*drug effects",
          "Male",
          "Mazindol/administration & dosage/*pharmacology/therapeutic use",
          "Mice",
          "Obesity/drug therapy/metabolism"
     ],
     "EDAT": "2014/08/22 06:00",
     "MHDA": "2016/05/02 06:00",
     "CRDT": [
          "2014/08/22 06:00"
     ],
     "PHST": [
          "2014/08/22 06:00 [entrez]",
          "2014/08/22 06:00 [pubmed]",
          "2016/05/02 06:00 [medline]"
     ],
     "AID": [
          "S0924270813000434 [pii]",
          "10.1017/neu.2013.43 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Acta Neuropsychiatr. 2014 Jun;26(3):146-54. doi: 10.1017/neu.2013.43.",
     "term": "hippocampus"
}